Filetype
This article is over 5 years old, and the information may therefore be outdated. Music professor Gary McPherson, appointed honorary doctor at the Faculty of Fine and Performing Arts, will be awarded in a digital ceremony at Lund University on May 28. Link to ceremony May 28
https://www.mhm.lu.se/en/article/online-doctoral-award-ceremony - 2026-06-21
The Academy of Music has the great pleasure of being able to distribute more than SEK 900,000 at the end of the school year in the form of various scholarships to the school's students. An important and tax-free addition to many students' wallets for the summer, which creates new opportunities, for example for further studies, instrument purchases or recordings.The Academy of Music has met one of
https://www.mhm.lu.se/en/article/malmo-academy-music-awards-almost-one-million-sek-scholarships - 2026-06-21
Göran Söllscher, professor at Malmö Academy of Music, is the first Swede to be awarded in the Hall of Fame for classical guitarists by the Guitar Foundation of America (GFA). Göran has known about the award for some time but was overwhelmed when he received the news. He thinks it proves that his musical achievements have been appreciated all over the world. Due to the pandemic, the ceremony and a
https://www.mhm.lu.se/en/article/goran-sollscher-honored-gfa-hall-fame - 2026-06-21
Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 19, she defends her thesis. She explains how better experimental models might improve future translational research on dyskinesia. You presented your research at the MultiPark Café recently. But for those who could not at
https://www.multipark.lu.se/article/why-dopamine-receptor-type-matters-phd-interview-katrine-skovgard - 2026-06-21
At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria
https://www.multipark.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2026-06-21
Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to pathological changes outside the brain. February 17, she defends her thesis about metabolic alterations in Huntington's disease. Now, she shares perspectives on her research journey. Tell us about your research! "Hunting
https://www.multipark.lu.se/article/huntingtons-metabolic-dysfunctions-phd-interview-elna-dickson - 2026-06-21
The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the plaques has not helped patients so far. Still, Tomas Roos thinks that Abeta matters, but we may need to focus on the aggregates elsewhere. On February 17, he defends his thesis about prion-like proteins in neurodegeneratio
https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-neurons-phd-interview-tomas-roos - 2026-06-21
On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been developed by Lund University and it is now being tested in patients for the first time. The transplantation product is generated from embryonic stem cells and functions to replace the dopamine nerve cells which are lost in the p
https://www.multipark.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2026-06-21
The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully grown electrodes in living tissue using the body’s molecules as triggers. The result, published in the journal Science, paves the way for the formation of fully integrated electronic circuits in living organisms. This news was initially publish
https://www.multipark.lu.se/article/electrodes-grown-brain - 2026-06-21
Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank sample collection. Here, she tells about the newly discovered genetic risk factor that might be specific to people in the southern part of Sweden. And is coffee really protective? Tell us about your research! “My research
https://www.multipark.lu.se/article/genes-and-environment-pd-phd-interview-kajsa-brolin - 2026-06-21
After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic stem cells were transplanted into the first Parkinson's patient at Skåne University Hospital. During the autumn 2022, the Swedish MPA (Läkemedelsverket) approved the clinical STEM-PD study. Several of MultiParks PIs hav
https://www.multipark.lu.se/article/stem-pd-bench-bedside-story-multipark-researchers-0 - 2026-06-21
Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional journey? Listen to MultiPark’s new podcast series “Meet our scientists”! In a newly launched podcast, young MultiPark researchers interview our research group leaders about their academic journey and main scientific foc
https://www.multipark.lu.se/article/meet-our-scientists-new-podcast-young-multipark-researchers - 2026-06-21
In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the door to world-leading transplantations for Parkinson's patients. Thanks to the pioneering basic research at MultiPark, stemcell-derived neural cells can now be tested in a clinical trial for the first time. In Parkinson's disease, the nerve cells in an area of the brain that con
https://www.multipark.lu.se/article/world-parkinsons-day-transplantations-parkinsons-disease-time-travel - 2026-06-21
Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neurodegenerative diseases is a new special interest group (SIG) addressing scientific and technological needs to unravel the genetics behind diseases such as Parkinson’s and Alzheimer’s. Andreas Puschmann tells about how h
https://www.multipark.lu.se/article/genetics-neurodegenerative-diseases-special-interest-group - 2026-06-21
Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. Two of them are MultiPark research leaders. They do research on chaperone proteins’ function in neurodegenerative diseases and blood tests for rapid screening of drugs in the treat
https://www.multipark.lu.se/article/double-success-multipark-research-groups-prestigious-eu-grant-round - 2026-06-21
Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceutical symposium sponsored by MultiPark. Sarah Tabrizi, a high profile Huntington researcher, and some of MultiPark's own researchers will speak. Medications are the physician's primary tool when treating their patients,
https://www.multipark.lu.se/article/superstars-coming-lund-pharmaceutical-symposium-sponsored-multipark - 2026-06-21
Recent studies indicate that acquired brain injuries, such as traumatic brain injury, trigger potentially harmful responses that may lead to neurodegenerative pathology. “Acquired brain injuries and their links to neurodegeneration diseases” is a new special interest group (SIG) collaborating across research groups to elucidate molecular processes that may mediate the relation between acquired bra
https://www.multipark.lu.se/article/acquired-brain-injuries-special-interest-group - 2026-06-21
Thanks to the recent development of diagnostic tools based on blood biomarkers linked to Alzheimer’s, it is possible to predict whether an individual will develop the disease. Therefore, MultiPark researchers gather across groups to investigate hidden opportunities and develop implementable tools also for other brain conditions with similar approaches. “Development and implementation of fluid biom
https://www.multipark.lu.se/article/fluid-biomarkers-special-interest-group - 2026-06-21
In April, the young MultiPark working group organized a photo competition entitled "Brain in Picture". The external jury has had a hard time choosing, but now, they have appointed the best entry. Congratulations to Ellinor Molnár, bachelor student in the Behavioral Neuroscience Laboratory, for a great picture and for winning the competition! The jury had the following motivation: The winning entry
https://www.multipark.lu.se/article/brain-picture-winning-photo - 2026-06-21
New research is underway at Lund University, led by Dr. Vivien Horvath, a postdoctoral researcher at Lund Stem Cell Center. Supported by a new grant from the Collaborative Center for X-Linked Dystonia-Parkinsonism (XDP), Vivien aims to improve our understanding of XDP, a rare neurodegenerative disorder caused by the recent insertion of a transposable element. Transposable elements, also known as '
https://www.multipark.lu.se/article/exploring-role-jumping-genes-x-linked-dystonia-parkinsonism - 2026-06-21
